-
1دورية أكاديمية
المؤلفون: Massiá, Mar, Padilla, Sergio, Moreno, Santiago, Barber, Xavier, Iribarren, José A., Romero, Jorge del, Gómez-Sirvent, Juan L., Rivero, María, Vidal, Francesc, Campins, Antonio A., Gutiérrez, Félix
المساهمون: Instituto de Salud Carlos III, European Commission
العلاقة: Publisher's version; https://doi.org/10.1371/journal.pone.0184329Test; Sí; PLoS ONE 12(9): e0184329 (2017); http://hdl.handle.net/10261/180806Test; http://dx.doi.org/10.13039/501100004587Test; http://dx.doi.org/10.13039/501100000780Test
الإتاحة: https://doi.org/10.1371/journal.pone.0184329Test
https://doi.org/10.13039/501100004587Test
https://doi.org/10.13039/501100000780Test
http://hdl.handle.net/10261/180806Test -
2دورية أكاديمية
المؤلفون: Masiá, Mar, Padilla, Sergio, Moreno, Santiago, Barber, Xavier, Iribarren, Jose A., del Romero, Jorge, Gómez-Sirvent, Juan L., Rivero, María, Vidal, Francesc, Campins, Antonio A., Gutiérrez, Félix, null, null
المصدر: PLoS ONE; 9/8/2017, Vol. 12 Issue 9, p1-16, 16p
مصطلحات موضوعية: HIV-positive persons, FOLLOW-up studies (Medicine), MEDICAL centers, CD4 antigen, TARGETED drug delivery